Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1974 Dec;50(590):729–733. doi: 10.1136/pgmj.50.590.729

Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness

C de B White, R B Royds, P Turner
PMCID: PMC2495996  PMID: 4469040

Abstract

In the treatment of fifteen patients with essential hypertension, in open trial indoramin caused a mean blood pressure fall from 180/115 mmHg to 159/98 mmHg. No reversal of antihypertensive effect was seen in four patients after additions of the tricyclic antidepressant drug desipramine. Blood pressure did not begin to rise in these four patients for at least 5 weeks after stopping indoramin. The implications of these findings are discussed.

Full text

PDF
729

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alps B. J., Hill M., Johnson E. S., Wilson A. B. Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy 21901). Br J Pharmacol. 1972 Jan;44(1):52–62. doi: 10.1111/j.1476-5381.1972.tb07237.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Briant R. H., Reid J. L., Dollery C. T. Interaction between clonidine and desipramine in man. Br Med J. 1973 Mar 3;1(5852):522–523. doi: 10.1136/bmj.1.5852.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brownlee G. Drugs which lower blood pressure. Trans Med Soc Lond. 1966;82:103–110. [PubMed] [Google Scholar]
  4. Collis M. G., Alps B. J. The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations. J Pharm Pharmacol. 1973 Aug;25(8):621–628. doi: 10.1111/j.2042-7158.1973.tb10648.x. [DOI] [PubMed] [Google Scholar]
  5. Lewis P. J., George C. F., Dollery C. T. Clinical evaluation of indoramin, a new antihypertensive agent. Eur J Clin Pharmacol. 1973 Dec;6(4):211–216. doi: 10.1007/BF00644733. [DOI] [PubMed] [Google Scholar]
  6. MCCUBBIN J. W., GREEN J. H., PAGE I. H. Baroceptor function in chronic renal hypertension. Circ Res. 1956 Mar;4(2):205–210. doi: 10.1161/01.res.4.2.205. [DOI] [PubMed] [Google Scholar]
  7. McCulloch M. W., Story D. F. Antagonism of noradrenaline and histamine by desipramine in the isolated artery of the rabbit ear. Br J Pharmacol. 1972 Sep;46(1):140–150. doi: 10.1111/j.1476-5381.1972.tb06856.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mitchell J. R., Cavanaugh J. H., Arias L., Oates J. A. Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest. 1970 Aug;49(8):1596–1604. doi: 10.1172/JCI106377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Perry H. M., Jr, Schroeder H. A., Catanzaro F. J., Moore-Jones D., Camel G. H. Studies on the control of hypertension. 8. Mortality, morbidity, and remissions during twelve years of intensive therapy. Circulation. 1966 Jun;33(6):958–972. doi: 10.1161/01.cir.33.6.958. [DOI] [PubMed] [Google Scholar]
  10. Persson I., Ulrich J. Treatment of hypertension with a new beta-blocking agent, pindolol (Visken). Eur J Clin Pharmacol. 1973 Dec;6(4):217–219. doi: 10.1007/BF00644734. [DOI] [PubMed] [Google Scholar]
  11. Prichard B. N., Gillam P. M. Treatment of hypertension with propranolol. Br Med J. 1969 Jan 4;1(5635):7–16. doi: 10.1136/bmj.1.5635.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Royds R. B., Coltart D. J., Lockhart J. D. Pharmacologic studies of indoramin in man. Clin Pharmacol Ther. 1972 May-Jun;13(3):380–392. doi: 10.1002/cpt1972133380. [DOI] [PubMed] [Google Scholar]
  13. Simpson F. O., Waal-Manning H. J. Hypertension and depression: interrelated problems in therapy. J R Coll Physicians Lond. 1971 Oct;6(1):14–24. [PMC free article] [PubMed] [Google Scholar]
  14. Thrum R. H., Smith W. M. On resetting of "barostats" in hypertensive patients. JAMA. 1967 Jul 31;201(5):301–304. doi: 10.1001/jama.201.5.301. [DOI] [PubMed] [Google Scholar]
  15. Variava D. H., Turner P. The alpha-adrenoceptor blocking effect of indoramin on human isolated smooth muscle. J Pharm Pharmacol. 1973 Aug;25(8):629–632. doi: 10.1111/j.2042-7158.1973.tb10649.x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES